Author

Shuying Yang

GSK - Cited by 709

Biography

Shuying Yang, Department of Periodontics, Laboratory of Tissue Regeneration and Immunology, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Tian Tan Xi Li, Beijing, China
Title
Cited by
Year
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
PT Lukey, SA Harrison, S Yang, Y Man, BF Holman, A Rashidnasab, ...European Respiratory Journal 53 (3), 2019201
99
2019
Multilevel models for censored and latent responses
S Rabe-Hesketh, S Yang, A PicklesStatistical Methods in Medical Research 10 (6), 409-427, 2001200
61
2001
The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study
LA Lee, S Yang, E Kerwin, R Trivedi, LD Edwards, S PascoeRespiratory medicine 109 (1), 54-62, 2015201
56
2015
A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma
LA Lee, A Briggs, LD Edwards, S Yang, S PascoeRespiratory medicine 109 (1), 63-73, 2015201
44
2015
Mid‐p confidence intervals for the poisson expectation
GR Cohen, SY YangStatistics in Medicine 13 (21), 2189-2203, 1994199
41
1994
A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with≤ 2% and> 2% blood …
J Marks-Konczalik, M Costa, J Robertson, E McKie, S Yang, S PascoeRespiratory Medicine 109 (7), 860-869, 2015201
37
2015
A randomized dose-escalation study of the safety and anti-inflammatory activity of the p38 mitogen-activated protein kinase inhibitor dilmapimod in severe trauma subjects at …
JD Christie, S Vaslef, PK Chang, AK May, SR Gunn, S Yang, K Hardes, ...Critical Care Medicine 43 (9), 1859-1869, 2015201
36
2015
A multicentre, randomized, double-blind, placebo-controlled, crossover study to investigate the efficacy, safety, tolerability, and pharmacokinetics of repeat doses of inhaled …
S Khindri, A Cahn, M Begg, M Montembault, C Leemereise, Y Cui, ...Journal of Pharmacology and Experimental Therapeutics 367 (3), 405-413, 2018201
32
2018
Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD
S Pascoe, M Costa, J Marks-Konczalik, E McKie, S Yang, PS ScherbovskyRespiratory Medicine 130, 20-26, 2017201
23
2017
The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
OS Usmani, MF Biddiscombe, S Yang, S Meah, E Oballa, JK Simpson, ...Respiratory Research 19, 1-10, 2018201
21
2018
Item response model adaptation for analyzing data from different versions of Parkinson’s disease rating scales
G Gottipati, AC Berges, S Yang, C Chen, MO Karlsson, EL PlanPharmaceutical research 36, 1-14, 2019201
17
2019
Evaluations of Bayesian and maximum likelihood methods in PK models with below‐quantification‐limit data
S Yang, J RogerPharmaceutical Statistics 9 (4), 313-330, 2010201
17
2010
A novel inhaled dry-powder formulation of ribavirin allows for efficient lung delivery in healthy participants and those with chronic obstructive pulmonary disease in a phase 1 …
EF Dumont, AJ Oliver, C Ioannou, J Billiard, J Dennison, F van den Berg, ...Antimicrobial Agents and Chemotherapy 64 (5), 10.1128/aac. 02267-19, 2020202
14
2020
The effect of umeclidinium on lung function and symptoms in patients with fixed airflow obstruction and reversibility to salbutamol: a randomised, 3-phase study
L Lee, E Kerwin, K Collison, L Nelsen, W Wu, S Yang, S PascoeRespiratory Medicine 131, 8-157, 2017201
14
2017
Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug–drug interaction studies
S Yang, M BeeraheeEuropean journal of clinical pharmacology 67, 225-233, 2011201
12
2011
Maximum likelihood
S Yang, D De AngelisComputational Toxicology: Volume II, 581-595, 2013201
12
2013
Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA)
PT Lukey, HC Perry, S Yang, S Parry, MC Dickson, VH Norris, PG Russell, ...Scientific Research Publishing, 202
12
2012
Changes in blood lead and water lead in Edinburgh. An eight year follow-up to the Edinburgh lead study
C Macintyre, M Fulton, W Hepburn, S Yang, G Raab, S Davis, M Heap, ...Environmental geochemistry and health 20, 157-167, 1998199
12
1998
Population pharmacokinetics of inhaled fluticasone furoate and vilanterol in subjects with chronic obstructive pulmonary disease
S Siederer, A Allen, S YangEuropean Journal of Drug Metabolism and Pharmacokinetics 41, 743-758, 2016201
11
2016
Losmapimod concentration–QT relationship in healthy volunteers: meta-analysis of data from six clinical trials
S Yang, M BeeraheeEuropean journal of clinical pharmacology 69, 1261-1267, 2013201
10
2013

Referred From: https://scholar.google.com/citations?hl=en&user=-NtxxYkAAAAJ

Cited by
Citations 709
h-index 14
i10-index 22
Recommended Journals
Open Access Journals